MedTrace Logo

Laryngeal Mask in Morbid Obesity

NCT04243564 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2023-12-05

No results posted yet for this study

Summary

Investigators study the performance of both masks, Proseal Laryngeal Mask Airway (PLMA) and I-gel, as temporary ventilatory supraglottic airway devices (SGDs) before tracheal intubation in morbidly obese patients. Data are lacking in such population of patients

Conditions

  • Morbid Obesity

Interventions

DEVICE

Supraglottic device (SGD)

Positioning of SGD as temporary ventilatory device before tracheal intubation

Sponsors & Collaborators

  • University of Padova

    lead OTHER

Principal Investigators

  • Michele Carron, MD · University of Padova

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-15
Primary Completion
2022-03-15
Completion
2022-06-15

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04243564 on ClinicalTrials.gov